| Revision as of 04:35, 16 June 2021 editSer Amantio di Nicolao (talk | contribs)Autopatrolled, Administrators6,299,281 edits →References: add categoryTag: AWB← Previous edit | Revision as of 04:01, 3 December 2021 edit undoRlink2 (talk | contribs)Extended confirmed users309,868 editsm →top: archive link repair, may include: archive.* -> archive.today, and http->https for ghostarchive.org and archive.org (wp:el#Specifying_protocols)Tag: AWBNext edit → | ||
| Line 2: | Line 2: | ||
| '''Paola Leone''', ], is a leading researcher of ], a ]. | '''Paola Leone''', ], is a leading researcher of ], a ]. | ||
| Dr. Leone was born and raised in ], ]. She received her undergraduate and graduate training in Italy, followed by post-doctoral studies in ] and ] in ]. She holds a doctorate degree in Neuroscience from the ].<ref>University of Medicine and Dentistry of New Jersey - </ref> Her work on Canavan disease started at Yale, where she collaborated with other early pioneers in ]. She left Yale in 1998 to join the (now defunct) Cell & Gene Therapy Center at ] in ] She now directs The Cell & Gene Therapy Center at the ].<ref>University of Medicine and Dentistry of New Jersey - {{webarchive|url=https://archive. |
Dr. Leone was born and raised in ], ]. She received her undergraduate and graduate training in Italy, followed by post-doctoral studies in ] and ] in ]. She holds a doctorate degree in Neuroscience from the ].<ref>University of Medicine and Dentistry of New Jersey - </ref> Her work on Canavan disease started at Yale, where she collaborated with other early pioneers in ]. She left Yale in 1998 to join the (now defunct) Cell & Gene Therapy Center at ] in ] She now directs The Cell & Gene Therapy Center at the ].<ref>University of Medicine and Dentistry of New Jersey - {{webarchive|url=https://archive.today/20090325090141/http://som.umdnj.edu/cgtweb/faculty/ |date=2009-03-25 }}.</ref><ref>{{Cite web|title=On the cusp of a cure for deadly childhood disease|url=https://today.rowan.edu/news/2020/11/on-the-cusp-of-a-cure-for-deadly-childhood-disease.html|access-date=2020-12-28|website=today.rowan.edu|language=en}}</ref><ref>{{Cite web|last=Ph.D|first=Miryam Z. Wahrman|title=Looking for cures|url=https://jewishstandard.timesofisrael.com/looking-for-cures/|access-date=2020-12-28|website=jewishstandard.timesofisrael.com|language=en-US}}</ref> | ||
| Recently, she has been funded by ]-] and Jacob's Cure to study the potential of subpopulations of stem cells to promote remyelination and phenotypic rescue in animal models of white matter disease, including the Canavan mouse model. She is currently generating pre-clinical data using human Embryonic-Derived-Oligodendrocyte Stem Cells provided by ] (CA). These studies will provide a foundation for a targeted and comprehensive analysis of the potential of a cell-based therapy for ].<ref></ref> | Recently, she has been funded by ]-] and Jacob's Cure to study the potential of subpopulations of stem cells to promote remyelination and phenotypic rescue in animal models of white matter disease, including the Canavan mouse model. She is currently generating pre-clinical data using human Embryonic-Derived-Oligodendrocyte Stem Cells provided by ] (CA). These studies will provide a foundation for a targeted and comprehensive analysis of the potential of a cell-based therapy for ].<ref></ref> | ||
Revision as of 04:01, 3 December 2021
Italian biologistPaola Leone, Ph.D., is a leading researcher of Canavan disease, a leukodystrophy.
Dr. Leone was born and raised in Cagliari, Italy. She received her undergraduate and graduate training in Italy, followed by post-doctoral studies in Montreal and Yale University in New Haven, CT. She holds a doctorate degree in Neuroscience from the University of Padua. Her work on Canavan disease started at Yale, where she collaborated with other early pioneers in gene therapy. She left Yale in 1998 to join the (now defunct) Cell & Gene Therapy Center at Thomas Jefferson University in Philadelphia, PA. She now directs The Cell & Gene Therapy Center at the University of Medicine and Dentistry of New Jersey.
Recently, she has been funded by NIH-NINDS and Jacob's Cure to study the potential of subpopulations of stem cells to promote remyelination and phenotypic rescue in animal models of white matter disease, including the Canavan mouse model. She is currently generating pre-clinical data using human Embryonic-Derived-Oligodendrocyte Stem Cells provided by Geron Corporation (CA). These studies will provide a foundation for a targeted and comprehensive analysis of the potential of a cell-based therapy for Canavan Disease.
References
- University of Medicine and Dentistry of New Jersey - Faculty and Research Interests
- University of Medicine and Dentistry of New Jersey - Cell and Gene Therapy Center Faculty and Staff Archived 2009-03-25 at archive.today.
- "On the cusp of a cure for deadly childhood disease". today.rowan.edu. Retrieved 2020-12-28.
- Ph.D, Miryam Z. Wahrman. "Looking for cures". jewishstandard.timesofisrael.com. Retrieved 2020-12-28.
- Jacob's Cure Canavan Disease Research -
 | This biography related to medicine in Italy is a stub. You can help Misplaced Pages by expanding it. |
- University of Padua alumni
- Yale University alumni
- Thomas Jefferson University faculty
- University of Medicine and Dentistry of New Jersey faculty
- Italian emigrants to the United States
- Italian biologists
- Italian women biologists
- 20th-century Italian scientists
- 20th-century women scientists
- 20th-century biologists
- 21st-century Italian scientists
- 21st-century women scientists
- 21st-century biologists
- Living people
- 20th-century Italian women
- 21st-century Italian women
- Italian medical biography stubs